Onderneming Respirerx Pharmaceuticals Inc Other OTC
Aandelen
US2205243007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-10-14 |
David Dickason
PRN | Corporate Officer/Principal | - | 15-09-20 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 01-10-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Director/Board Member | - | 22-03-23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 365 418 647 | 341 184 734 ( 93,37 %) | 0 | 93,37 % |
Aandeel B | 0 | 37 500 | 0 | 0 |
Bedrijfsgegevens
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,76% | 111 mld. | |
+11,24% | 106 mld. | |
-12,35% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,61% | 16,81 mld. | |
+38,91% | 12,54 mld. | |
-24,32% | 8,09 mld. |
- Beurs
- Aandelen
- Koers RSPI
- Koers
- Onderneming Respirerx Pharmaceuticals Inc